Sign up to save your podcasts
Or
Share 100% Bullish: Simvastatin in MS, Communicating Risk
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
100% Bullish: Simvastatin in MS, Communicating Risk
This week: Simvastatin in Secondary Progressive Multiple Sclerosis and Communicating With Patients About Risk Rebecca and Amol want you to: 1. Recognize that simvastatin reduces the rate of whole brain atrophy in secondary progressive MS, which may be a promising new use for statins. 2. Understand that effective strategies to communicate risk include: Using visual aids, speaking ...
The post 100% Bullish: Simvastatin in MS, Communicating Risk appeared first on Healthy Debate.
View all episodes
By Dr. John Fralick and Dr. Michael Fralick
5
1212 ratings
This week: Simvastatin in Secondary Progressive Multiple Sclerosis and Communicating With Patients About Risk Rebecca and Amol want you to: 1. Recognize that simvastatin reduces the rate of whole brain atrophy in secondary progressive MS, which may be a promising new use for statins. 2. Understand that effective strategies to communicate risk include: Using visual aids, speaking ...
The post 100% Bullish: Simvastatin in MS, Communicating Risk appeared first on Healthy Debate.
More shows like The Rounds Table
View all
JAMA Editors' Summary
129 Listeners
Emergency Medicine Cases
538 Listeners
Core EM - Emergency Medicine Podcast
250 Listeners
JAMA Clinical Reviews
493 Listeners
GeriPal - A Geriatrics and Palliative Care Podcast
285 Listeners
The Curbsiders Internal Medicine Podcast
3,332 Listeners
Core IM | Internal Medicine Podcast
1,095 Listeners
Annals On Call Podcast
185 Listeners
The Clinical Problem Solvers
515 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
349 Listeners
Run the List
248 Listeners
Cardionerds: A Cardiology Podcast
426 Listeners
Critical Care Scenarios
249 Listeners
The Curious Clinicians
366 Listeners
Critical Care Time
233 Listeners